Immune Checkpoint Inhibitors and RCC: Where Are We Now?
This case based panel discussion reviews the recent guidelines and the latest clinical information related to the treatment of RCC with immunotherapeutic agents.
This site uses cookies. By continuing to use this website, you agree to their use. For details, please check our Privacy Policy.
